
Buyers evaluate life insurance policies using actuarial models and financial analysis designed to estimate how long the policy may remain active and how much it will cost to maintain over time. The goal of this evaluation is to determine the investment value of the policy based on expected premiums and the future death benefit.
Medical records play an important role in this process because they help independent life expectancy providers estimate longevity. Buyers typically review existing medical history, diagnoses, prescription records, and other health information to develop a life expectancy assessment. This review uses existing records only and generally does not require the policyholder to undergo any new medical exams or testing.
In addition to health information, buyers carefully review the structure of the life insurance policy itself. Important factors include the policy’s face value, premium schedule, cash value, guaranteed periods, and the financial strength of the insurance carrier. These details help buyers estimate how much they will need to invest in premiums over time in order to keep the policy active until the death benefit is paid.
Because buyers are assuming the responsibility of paying future premiums, both life expectancy estimates and policy costs play a major role in determining the settlement offer. Policies with lower premium costs or more stable structures may generate higher offers, while policies with higher ongoing costs or more complex structures may receive lower offers.
Throughout the evaluation process, all information is handled by licensed professionals who follow strict privacy and confidentiality rules. Medical and financial records are used solely to evaluate the policy and are protected under applicable privacy laws and industry standards.
